Finland-based Adalyon, a tech-bio company using its AI-powered speech biomarker platform to transform clinical drug development, has appointed Ulrik Zeuthen as CEO. Adalyon’s proprietary speech-based digital biomarkers provide actionable insights…
Finland: Adalyon appoints Ulrik Zeuthen as CEO to drive next phase of growth
…
…






